Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of GBP 214.53 million. The enterprise value is 204.09 million.

Market Cap	214.53M
Enterprise Value	204.09M

Important Dates

The last earnings date was Tuesday, April 8, 2025.

Earnings Date	Apr 8, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.64M

Valuation Ratios

The trailing PE ratio is 29.39.

PE Ratio	29.39
Forward PE	n/a
PS Ratio	5.49
PB Ratio	6.99
P/TBV Ratio	8.09
P/FCF Ratio	22.27
P/OCF Ratio	21.32
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.19, with an EV/FCF ratio of 21.18.

EV / Earnings	27.96
EV / Sales	5.09
EV / EBITDA	18.19
EV / EBIT	21.59
EV / FCF	21.18

Financial Position

The company has a current ratio of 4.00, with a Debt / Equity ratio of 0.08.

Current Ratio	4.00
Quick Ratio	2.41
Debt / Equity	0.08
Debt / EBITDA	0.22
Debt / FCF	0.25
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 24.88% and return on invested capital (ROIC) is 18.48%.

Return on Equity (ROE)	24.88%
Return on Assets (ROA)	15.16%
Return on Invested Capital (ROIC)	18.48%
Return on Capital Employed (ROCE)	28.03%
Revenue Per Employee	253,918
Profits Per Employee	47,405
Employee Count	154
Asset Turnover	1.03
Inventory Turnover	0.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.83% in the last 52 weeks. The beta is 0.76, so Medistim ASA's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-14.83%
50-Day Moving Average	161.80
200-Day Moving Average	198.32
Relative Strength Index (RSI)	44.10
Average Volume (20 Days)	215

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of GBP 39.10 million and earned 7.30 million in profits. Earnings per share was 0.40.

Revenue	39.10M
Gross Profit	31.11M
Operating Income	9.22M
Pretax Income	9.44M
Net Income	7.30M
EBITDA	10.32M
EBIT	9.22M
Earnings Per Share (EPS)	0.40

Full Income Statement

Balance Sheet

The company has 12.60 million in cash and 2.42 million in debt, giving a net cash position of 10.18 million.

Cash & Cash Equivalents	12.60M
Total Debt	2.42M
Net Cash	10.18M
Net Cash Per Share	n/a
Equity (Book Value)	30.70M
Book Value Per Share	1.68
Working Capital	22.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.06 million and capital expenditures -426,635, giving a free cash flow of 9.63 million.

Operating Cash Flow	10.06M
Capital Expenditures	-426,635
Free Cash Flow	9.63M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 79.56%, with operating and profit margins of 23.57% and 18.67%.

Gross Margin	79.56%
Operating Margin	23.57%
Pretax Margin	24.14%
Profit Margin	18.67%
EBITDA Margin	26.39%
EBIT Margin	23.57%
FCF Margin	24.64%

Dividends & Yields

This stock pays an annual dividend of 0.33, which amounts to a dividend yield of 0.20%.

Dividend Per Share	0.33
Dividend Yield	0.20%
Dividend Growth (YoY)	-3.70%
Years of Dividend Growth	n/a
Payout Ratio	79.37%
Buyback Yield	-0.10%
Shareholder Yield	0.11%
Earnings Yield	3.40%
FCF Yield	4.49%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medistim ASA has an Altman Z-Score of 17.36.

Altman Z-Score	17.36
Piotroski F-Score	n/a